Application segmentation of the Sugar-Free Probiotic Oral Liquid market isolates four primary use‑cases that together shape demand dynamics. Dental care products, accounting for roughly 35 % of sales, target plaque reduction and caries prevention through competitive exclusion of pathogenic bacteria. Digestive‑health applications, representing about 25 %, leverage the oral‑gut axis, positioning the liquid as a pre‑emptive modulator of gastrointestinal microbiota. Immune‑support variants, with an estimated 20 % share, focus on enhancing mucosal immunity by reinforcing the oral barrier against opportunistic pathogens. The remaining 20 % falls under general oral hygiene, where the formulation serves as a daily maintenance agent without disease‑specific claims. Each segment contributes proportionally to total market size, reflecting differing consumer priorities and reimbursement pathways. The relative weighting of these applications is a core element of Sugar-Free Probiotic Oral Liquid segmentation, informing product‑development pipelines and geographic rollout strategies.